NEW YORK (GenomeWeb) – In a filing yesterday with the US Securities and Exchange Commission, BG Medicine said it has decided to voluntarily deregister its common stock and become a non-reporting company.

The company said it made this decision due to the "significant cost and resource demands of being a public company," noting as well that following deregistration it will no longer publish periodic financial information or furnish such information to its shareholders other than that which is required by law.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.